UBS Group’s IGC Pharma IGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.1K Buy
36,308
+36,307
+3,630,700% +$11.1K ﹤0.01% 7480
2025
Q1
$0 Sell
1
-3,117
-100% ﹤0.01% 9055
2024
Q4
$1.05K Buy
+3,118
New +$1.05K ﹤0.01% 8074
2024
Q1
Sell
-4,747
Closed -$1.33K 8354
2023
Q4
$1.33K Buy
4,747
+4,453
+1,515% +$1.25K ﹤0.01% 7123
2023
Q3
$106 Hold
294
﹤0.01% 7722
2023
Q2
$92 Hold
294
﹤0.01% 7437
2023
Q1
$100 Hold
294
﹤0.01% 8144
2022
Q4
$94 Hold
294
﹤0.01% 9208
2022
Q3
$0 Sell
294
-15,885
-98% ﹤0.01% 9425
2022
Q2
$8K Buy
16,179
+3,229
+25% +$1.6K ﹤0.01% 7269
2022
Q1
$12K Sell
12,950
-2,497
-16% -$2.31K ﹤0.01% 7129
2021
Q4
$15K Sell
15,447
-40,380
-72% -$39.2K ﹤0.01% 7127
2021
Q3
$82K Buy
55,827
+47,399
+562% +$69.6K ﹤0.01% 4885
2021
Q2
$14K Buy
8,428
+7,037
+506% +$11.7K ﹤0.01% 6606
2021
Q1
$3K Sell
1,391
-28,774
-95% -$62.1K ﹤0.01% 7473
2020
Q4
$47K Buy
30,165
+16,008
+113% +$24.9K ﹤0.01% 5249
2020
Q3
$15K Buy
+14,157
New +$15K ﹤0.01% 5645
2020
Q2
Sell
-365
Closed 7176
2020
Q1
$0 Sell
365
-12,464
-97% ﹤0.01% 7100
2019
Q4
$8K Buy
12,829
+9,916
+340% +$6.18K ﹤0.01% 6311
2019
Q3
$3K Buy
+2,913
New +$3K ﹤0.01% 6663
2019
Q2
Sell
-5,727
Closed -$12K 7039
2019
Q1
$12K Buy
+5,727
New +$12K ﹤0.01% 5849
2018
Q4
Sell
-2,991
Closed -$19K 7130
2018
Q3
$19K Sell
2,991
-585
-16% -$3.72K ﹤0.01% 5905
2018
Q2
$2K Buy
+3,576
New +$2K ﹤0.01% 6793
2017
Q4
Sell
-29,838
Closed -$11K 6898
2017
Q3
$11K Sell
29,838
-41,884
-58% -$15.4K ﹤0.01% 5913
2017
Q2
$29K Buy
71,722
+67,837
+1,746% +$27.4K ﹤0.01% 5101
2017
Q1
$2K Sell
3,885
-30,416
-89% -$15.7K ﹤0.01% 6352
2016
Q4
$10K Buy
34,301
+28,647
+507% +$8.35K ﹤0.01% 5960
2016
Q3
$3K Buy
+5,654
New +$3K ﹤0.01% 6340
2016
Q2
Sell
-13,128
Closed -$7K 6840
2016
Q1
$7K Buy
13,128
+3,023
+30% +$1.61K ﹤0.01% 5997
2015
Q4
$2K Buy
10,105
+5,968
+144% +$1.18K ﹤0.01% 6582
2015
Q3
$1K Sell
4,137
-7,439
-64% -$1.8K ﹤0.01% 6700
2015
Q2
$5K Buy
+11,576
New +$5K ﹤0.01% 6281
2015
Q1
Sell
-7,048
Closed -$5K 6718
2014
Q4
$5K Buy
+7,048
New +$5K ﹤0.01% 6343